# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stifel analyst Mathew Blackman maintains Inogen (NASDAQ:INGN) with a Hold and raises the price target from $6 to $7.
Needham analyst Mike Matson reiterates Inogen (NASDAQ:INGN) with a Hold.
Inogen (NASDAQ:INGN) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.76) by 40....
Needham analyst Mike Matson reiterates Inogen (NASDAQ:INGN) with a Hold.
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow t...
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Inogen reported Q4 2023 revenues of $75.9 million, missing consensus. Despite challenges, the company's improvements positi...